Indutrade AB (OTCPK:IDDWF)
$ 26.45 -2.03 (-7.13%) Market Cap: 7.14 Bil Enterprise Value: 7.97 Bil PE Ratio: 27.17 PB Ratio: 3.83 GF Score: 94/100

Q4 2025 Indutrade AB Earnings Call Transcript

Jan 29, 2026 / 08:30AM GMT
Release Date Price: $26.45

Key Points

Positve
  • Indutrade AB (IDTRY) reported a 2% total growth in order intake for 2025, with organic growth also at 2%.
  • The company acquired 13 profitable companies during the year, contributing to a total annual turnover of 1.3 billion SEK.
  • Cash flow from operating activities remained strong at 1.6 billion SEK, consistent with high levels from the previous year.
  • The underlying EBITDA margin improved to 14.9% when excluding extraordinary one-offs, compared to 14.3% last year.
  • Indutrade AB (IDTRY) maintained a strong financial position with a net debt/EBITDA ratio of 1.4%, indicating low leverage.
Negative
  • Net sales decreased by 1% in total, with a 2% organic decline, primarily due to backlog reductions from previous years.
  • The reported EBITDA margin for Q4 was 13.3%, down from 14.6% in the same period last year, impacted by extraordinary one-offs.
  • Earnings per share decreased by 14% in Q4 to 1.72 SEK, and by 7% for the full year, affected by one-off items.
  • Sales in North America and Asia were down compared to last year, partly due to weaker demand in the technology and system solutions business area.
  • The business area technology and system solutions faced project revenue recognition adjustments, impacting organic growth negatively.
Operator

Welcome to the Indurade Q4 presentation for 2025. During the questions and answer session, participants are able to ask questions.

Now I will hand the conference over to CEO, Bo Annvik and CFO, Patrick Johnson. Please go ahead.

Bo Annvik
Indutrade AB - President, Chief Executive Officer, Executive Director

Welcome and good morning on our behalf as well. Let's start with a summary of the year 2025. It was a year with market uncertainty and continued dampened demand, although conditions improved throughout the year.

We improved operationally and financially gradually during the year and we also further strengthened our long-term strategic capability. As our new segment structure now is fully established. In terms of financial numbers, 2% total growth in order intake, organically also plus 2%.

Net sales decreased by 1% in total, of which 2% organically, driven mainly by backlog reductions during 2023 and 2024. The EBITDA margin of 13.8%, excluding extraordinary run-offs in the year, the beta margin came in at 14.1%. The cash flow was

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot